Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to improve the targeting of cancer drugs to tumours.

None © Celsion

Events

Intranet Files

Faculty development

Faculty development

Work experience and electives

Resources

News and events

School visits

Patient and Public Involvement (PPI)

Clinical course

Clinical course

Students

Undergraduate education

Surgical Teaching Leads

Teaching

Patient and public engagement

Information about public and patient engagement with the study

News and publications

Latest news and publications

VANGUARD PATH

VANGUARD PATH homepage

Background

Background

Study aims

Information on the study and its aims

Digital pathology and AI – Advances in techniques and technology

Description of advances in pathology

Documents

Load More

Meet the lead author of the study

  • Paul Lyon
    Paul Lyon

    Senior Research Fellow in Interventional Oncology

Categories

Similar stories